Teva Pharmaceutical Industries Ltd (TEVA)
14.06
+0.08
(+0.57%)
USD |
NYSE |
May 06, 16:00
14.06
0.00 (0.00%)
After-Hours: 18:24
Teva Pharmaceutical Industries Cash from Operations (Quarterly): 1.184B for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.184B |
| September 30, 2023 | 5.00M |
| June 30, 2023 | 324.00M |
| March 31, 2023 | -145.00M |
| December 31, 2022 | 973.00M |
| September 30, 2022 | 543.00M |
| June 30, 2022 | 123.00M |
| March 31, 2022 | -49.00M |
| December 31, 2021 | 456.00M |
| September 30, 2021 | 529.00M |
| June 30, 2021 | 218.00M |
| March 31, 2021 | -405.00M |
| December 31, 2020 | 331.00M |
| September 30, 2020 | 307.00M |
| June 30, 2020 | 273.00M |
| March 31, 2020 | 305.00M |
| December 31, 2019 | 538.00M |
| September 30, 2019 | 325.00M |
| June 30, 2019 | -227.00M |
| March 31, 2019 | 112.00M |
| December 31, 2018 | 367.00M |
| September 30, 2018 | 421.00M |
| June 30, 2018 | 162.00M |
| March 31, 2018 | 1.496B |
| December 31, 2017 | 859.00M |
| Date | Value |
|---|---|
| September 30, 2017 | 795.00M |
| June 30, 2017 | 435.00M |
| March 31, 2017 | 136.00M |
| December 31, 2016 | 90.00M |
| September 30, 2016 | 1.461B |
| June 30, 2016 | 963.00M |
| March 31, 2016 | 1.376B |
| December 31, 2015 | 1.615B |
| September 30, 2015 | 1.093B |
| June 30, 2015 | 1.48B |
| March 31, 2015 | 1.354B |
| December 31, 2014 | 1.752B |
| September 30, 2014 | 1.424B |
| June 30, 2014 | 1.053B |
| March 31, 2014 | 898.00M |
| December 31, 2013 | 816.00M |
| September 30, 2013 | 444.00M |
| June 30, 2013 | 875.00M |
| March 31, 2013 | 1.102B |
| December 31, 2012 | 1.577B |
| September 30, 2012 | 1.048B |
| June 30, 2012 | 1.191B |
| March 31, 2012 | 756.00M |
| December 31, 2011 | 1.428B |
| September 30, 2011 | 482.00M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-405.00M
Minimum
Mar 2021
1.184B
Maximum
Dec 2023
295.16M
Average
307.00M
Median
Sep 2020
Cash from Operations (Quarterly) Benchmarks
| Viatris Inc | 479.40M |
| Alvotech | -67.16M |
| AstraZeneca PLC | 2.486B |
| Corcept Therapeutics Inc | 5.887M |
| GSK PLC | 1.215B |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 301.00M |
| Cash from Financing (Quarterly) | -576.00M |
| Free Cash Flow | 842.00M |
| Free Cash Flow Per Share (Quarterly) | 0.9517 |
| Free Cash Flow to Equity (Quarterly) | 1.206B |
| Free Cash Flow to Firm (Quarterly) | 1.327B |
| Free Cash Flow Yield | 5.34% |